Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viola Melone

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Breast Cancer Research : BCR|July 19, 2022
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancerAnnamaria Salvati, Viola Melone, Assunta Sellitto, et al.
Cancer Cell International|November 5, 2022
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancerElena Alexandrova, Jessica Lamberti, Domenico Memoli, et al.
Frontiers in Genetics|May 2, 2022
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid TumorsElena Alexandrova, Annamaria Salvati, Giovanni Pecoraro, et al.
Cell Death & Disease|February 8, 2025
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancerViola Melone, Domenico Palumbo, Luigi Palo, et al.
Cancers|June 10, 2020
An Overview of Candidate Therapeutic Target Genes in Ovarian CancerElena Alexandrova, Giovanni Pecoraro, Assunta Sellitto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2026
Natural Killer Subset Changes and Vascular Endothelial Growth Factor-A Plasma Profile in Progressive Supranuclear Palsy: The NKscape StudyMarina Picillo, Cristina Basile, Francesco Montella, et al.
International Journal of Molecular Sciences|January 21, 2023
Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer ManagementViola Melone, Annamaria Salvati, Noemi Brusco, et al.
Cell Communication and Signaling : CCS|January 31, 2026
Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and meninViola Melone, Annamaria Salvati, Luigi Palo, et al.
Cell Death Discovery|October 6, 2025
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic targetElena Alexandrova, Roberto Parisi, Marharyta Smal, et al.
Scientific Data|January 15, 2026
Comprehensive Transcriptome Profiling of Sporadic Medullary Thyroid CarcinomasDomenico Palumbo, Viola Melone, Luigi Palo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Breast Cancer Research : BCR|July 19, 2022
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancerAnnamaria Salvati, Viola Melone, Assunta Sellitto, et al.
Cancer Cell International|November 5, 2022
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancerElena Alexandrova, Jessica Lamberti, Domenico Memoli, et al.
Frontiers in Genetics|May 2, 2022
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid TumorsElena Alexandrova, Annamaria Salvati, Giovanni Pecoraro, et al.
Cell Death & Disease|February 8, 2025
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancerViola Melone, Domenico Palumbo, Luigi Palo, et al.
Cancers|June 10, 2020
An Overview of Candidate Therapeutic Target Genes in Ovarian CancerElena Alexandrova, Giovanni Pecoraro, Assunta Sellitto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2026
Natural Killer Subset Changes and Vascular Endothelial Growth Factor-A Plasma Profile in Progressive Supranuclear Palsy: The NKscape StudyMarina Picillo, Cristina Basile, Francesco Montella, et al.
International Journal of Molecular Sciences|January 21, 2023
Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer ManagementViola Melone, Annamaria Salvati, Noemi Brusco, et al.
Cell Communication and Signaling : CCS|January 31, 2026
Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and meninViola Melone, Annamaria Salvati, Luigi Palo, et al.
Cell Death Discovery|October 6, 2025
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic targetElena Alexandrova, Roberto Parisi, Marharyta Smal, et al.
Scientific Data|January 15, 2026
Comprehensive Transcriptome Profiling of Sporadic Medullary Thyroid CarcinomasDomenico Palumbo, Viola Melone, Luigi Palo, et al.
Pageof 2